Cargando…

Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa

Substance use (SU) is associated with poor rifampicin-resistant tuberculosis (RR-TB) treatment outcomes. In 2017, a SBIRT (SU screening-brief intervention-referral to treatment) was integrated into routine RR-TB care in Khayelitsha, South Africa. This was a retrospective study of persons with RR-TB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuter, Anja, Beko, Buci, Memani, Boniwe, Furin, Jennifer, Daniels, Johnny, Rodriguez, Erickmar, Reuter, Hermann, Weich, Lize, Isaakidis, Petros, von der Heyden, Erin, Kock, Yulene, Mohr-Holland, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879094/ https://www.ncbi.nlm.nih.gov/pubmed/35202216 http://dx.doi.org/10.3390/tropicalmed7020021

Ejemplares similares

Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr-Holland, Erika, et al.
Publicado: (2020)

Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa
por: Mohr, Erika, et al.
Publicado: (2018)

Outcomes of Children Born to Pregnant Women With Drug-resistant Tuberculosis Treated With Novel Drugs in Khayelitsha, South Africa: A Report of Five Patients
por: Acquah, Rebecca, et al.
Publicado: (2021)

Pediatric delamanid treatment for children with rifampicin-resistant TB
por: Tyeku, N., et al.
Publicado: (2022)

“Life continues”: Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr, Erika, et al.
Publicado: (2018)

Early mortality during rifampicin-resistant TB treatment
por: Mohr-Holland, E., et al.
Publicado: (2022)

Tuberculosis Diagnosis and Preventive Monotherapy Among Children and Adolescents Exposed to Rifampicin-Resistant Tuberculosis in the Household
por: Apolisi, Ivy, et al.
Publicado: (2023)

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
por: Mohr-Holland, E., et al.
Publicado: (2021)

Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa
por: Apolisi, Ivy, et al.
Publicado: (2022)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

A very sneaky bug: perspectives of front-line clinicians on whole-genome sequencing for drug-resistant TB
por: Memani, B., et al.
Publicado: (2022)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting
por: Mohr, Erika, et al.
Publicado: (2017)

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success
por: Daniels, Johnny Flippie, et al.
Publicado: (2015)

“This is not my body”: Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis
por: Loveday, Marian, et al.
Publicado: (2021)

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2015)

Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study
por: Cox, Helen, et al.
Publicado: (2022)

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic
por: Mohr-Holland, Erika, et al.
Publicado: (2021)

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Cox, Helen, et al.
Publicado: (2021)

‘Only twice a year’: a qualitative exploration of 6-month antiretroviral treatment refills in adherence clubs for people living with HIV in Khayelitsha, South Africa
por: Keene, Claire Marriott, et al.
Publicado: (2020)

Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa
por: Cox, Helen, et al.
Publicado: (2015)

Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa
por: Patten, Gabriela EM, et al.
Publicado: (2013)

Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis
por: Tack, Ilse, et al.
Publicado: (2020)

Pragmatic fluid optimization in high-risk surgery patients: when pragmatism dilutes the benefits
por: Reuter, Daniel A
Publicado: (2012)

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
por: Mohr-Holland, E., et al.
Publicado: (2021)

An analysis of the HIV testing cascade of a group of HIV-exposed infants from birth to 18 months in peri-urban Khayelitsha, South Africa
por: Nelson, Aurelie Kennedy, et al.
Publicado: (2022)

Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa
por: Moyo, Sizulu, et al.
Publicado: (2015)

“Take the treatment and be brave”: Care experiences of pregnant women with rifampicin-resistant tuberculosis
por: Loveday, Marian, et al.
Publicado: (2020)

Barriers to involvement of men in ANC and VCT in Khayelitsha, South Africa
por: Mohlala, Boshishi K.F., et al.
Publicado: (2012)

Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?
por: Benbaba, Stella, et al.
Publicado: (2015)

Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study
por: Goig, Galo A, et al.
Publicado: (2023)

Information-seeking in first visit pregnant women in Khayelitsha, South Africa
por: Noncungu, Thabani M., et al.
Publicado: (2020)

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha
por: Sossen, Bianca, et al.
Publicado: (2021)

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
por: Ndjeka, Norbert, et al.
Publicado: (2020)

Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2013)

The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis
por: Cleary, Susan M, et al.
Publicado: (2006)

Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study
por: Kaplan, Samantha R., et al.
Publicado: (2017)

The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis
por: Abulfathi, Ahmed A., et al.
Publicado: (2021)

Mental health spillovers and the Millennium Development Goals: The case of perinatal depression in Khayelitsha, South Africa
por: Tsai, Alexander C., et al.
Publicado: (2012)

Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa: A Mathematical Model
por: Gonsalves, Gregg S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c40fe9to3t053i2uiat7889d6v